Page last updated: 2024-09-05

opc 28326 and talipexole

opc 28326 has been researched along with talipexole in 1 studies

Compound Research Comparison

Studies
(opc 28326)
Trials
(opc 28326)
Recent Studies (post-2010)
(opc 28326)
Studies
(talipexole)
Trials
(talipexole)
Recent Studies (post-2010) (talipexole)
911426212

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, A; Imaizumi, T; Kambe, T; Kishi, M; Mori, T; Nakazawa, T; Orito, K1

Other Studies

1 other study(ies) available for opc 28326 and talipexole

ArticleYear
alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
    British journal of pharmacology, 2001, Volume: 134, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aniline Compounds; Animals; Azepines; Binding, Competitive; Blood Pressure; Brimonidine Tartrate; Decerebrate State; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Mydriasis; Piperidines; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Vas Deferens; Vasodilator Agents; Yohimbine

2001